These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30901331)

  • 1. Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
    Phillips PPJ; Mitnick CD; Neaton JD; Nahid P; Lienhardt C; Nunn AJ
    PLoS Med; 2019 Mar; 16(3):e1002767. PubMed ID: 30901331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Tuberculosis: Therapeutics.
    Singh V; Kabra SK
    Indian J Pediatr; 2019 Aug; 86(8):700-702. PubMed ID: 31209764
    [No Abstract]   [Full Text] [Related]  

  • 3. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 4. Tuberculosis in transplant recipients: diagnostic and therapeutic dilemmas.
    Subramanian AK; Nuermberger EL
    Transpl Infect Dis; 2008 Jul; 10(4):229-30. PubMed ID: 18755013
    [No Abstract]   [Full Text] [Related]  

  • 5. Adaptive clinical trials in tuberculosis: applications, challenges and solutions.
    Davies GR; Phillips PP; Jaki T
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):626-34. PubMed ID: 25946350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ending TB: the world's oldest pandemic.
    Kim PS; Swaminathan S
    J Int AIDS Soc; 2021 Mar; 24(3):e25698. PubMed ID: 33754449
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tuberculosis--the forgotten part of the HIV epidemic].
    Trøseid M; Handal N; Holen Ø
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2712-4. PubMed ID: 17952165
    [No Abstract]   [Full Text] [Related]  

  • 8. The Global Landscape of Tuberculosis Therapeutics.
    Tornheim JA; Dooley KE
    Annu Rev Med; 2019 Jan; 70():105-120. PubMed ID: 30403551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tuberculosis: new treatment options and updated recommendations].
    Schaberg T
    Dtsch Med Wochenschr; 2013 Apr; 138(14):725-7. PubMed ID: 23533039
    [No Abstract]   [Full Text] [Related]  

  • 11. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
    Denholm J
    J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on tuberculosis: TB in the early 21st century.
    Connell DW; Berry M; Cooke G; Kon OM
    Eur Respir Rev; 2011 Jun; 20(120):71-84. PubMed ID: 21632795
    [No Abstract]   [Full Text] [Related]  

  • 13. Zero deaths from tuberculosis: progress, reality, and hope.
    Zumla A; Kim P; Maeurer M; Schito M
    Lancet Infect Dis; 2013 Apr; 13(4):285-7. PubMed ID: 23531385
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological issues in the design of clinical trials for the treatment of multidrug-resistant tuberculosis: challenges and opportunities.
    Lienhardt C; Davies G
    Int J Tuberc Lung Dis; 2010 May; 14(5):528-37. PubMed ID: 20392344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis in childhood.
    Shingadia D
    Ther Adv Respir Dis; 2012 Jun; 6(3):161-71. PubMed ID: 22361927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis: an ancient and evergreen disease.
    Migliori GB; D'Ambrosio L; Centis R
    Eur Respir Rev; 2011 Jun; 20(120):69-70. PubMed ID: 21632794
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress and challenges in childhood tuberculosis.
    Marais BJ; Graham SM; Maeurer M; Zumla A
    Lancet Infect Dis; 2013 Apr; 13(4):287-9. PubMed ID: 23531386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of tuberculosis and its challenges].
    Ma Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Aug; 31(4):389-92. PubMed ID: 19771720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High incidence and resistance rates in Eastern Europe. Is tuberculosis coming back?].
    Hauer B
    MMW Fortschr Med; 2004 Jun; 146(25):14. PubMed ID: 15354877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.